
News from European Pharmaceutical Manufacturer
Top European Pharmaceutical Manufacturer News

PharmaPolpharma Biologics has announced that it has signed licensing agreements with MS Pharma for the commercialisation of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region.See the Story
Polpharma Biologics and MS Pharma Sign Licensing Agreements for ...
100% Center coverage: 1 sources

Aptamer Signs Therapeutic Development Agreement with Invizius
100% Center coverage: 1 sources

Qureight Appoints Craig Rhodes as Head of Partnerships to Lead on Pharma Relationship Management
100% Center coverage: 1 sources